Skip to main content
. 2025 Jun 2;25:988. doi: 10.1186/s12885-025-14418-z

Table 2.

Association between PNMLR and clinicopathological features

Variables Univariate Multivariate
OR (95%CI) p-value OR (95%CI) p-value
Age (Every 10 years) 1.21 (0.94, 1.51) 0.138
Sex (Female vs. Male) 0.70 (0.54, 0.91) 0.007 0.85 (0.63, 1.16) 0.246
Smoking history (Yes vs. No) 1.37 (1.05, 1.79) 0.021 1.28 (0.94, 1.79) 0.162
Hypertension (Yes vs. No) 1.49 (1.12, 1.99) 0.006 1.41 (1.05, 1.91) 0.028
Diabetes mellitus (Yes vs. No) 1.62 (1.16, 2.25) 0.004 1.39 (1.02, 1.99) 0.042
ECOG status (1 vs. 0) 1.27 (0.98, 1.65) 0.072
Side (Right vs. Left) 0.97 (0.76, 1.24) 0.797
Tumor size (Every 1 cm) 1.18 (109, 1.33) 0.001 1.16 (1.03, 1.43) 0.028
pT (Local advanced vs. Localized) 2.34 (1.57, 3.48)  < 0.001 1.88 (1.26, 2.87) 0.003
Histology type (Non-ccRCC vs. ccRCC) 1.21 (0.78, 1.86) 0.399
Fuhrman grade (High vs. Low) 1.75 (1.37, 2.25)  < 0.001 1.59 (1.22, 2.05) 0.001

Abbreviations: PNMLR Platelet-Neutrophil-Monocyte-Lymphocyte ratio, OR odds ratio, ECOG Eastern Cooperative Oncology Group, pT pathological stage, ccRCC clear cell renal cell carcinoma